FIELD: medicine. SUBSTANCE: method involves determining TNFα in lacrimal fluid of ill eye. The value being greater than 140 pcg/ml, leiomyoma is to be diagnosed, otherwise iris melanoma is to be diagnosed. EFFECT: enhanced accuracy of diagnosis.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 1998 |
|
RU2146823C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 2001 |
|
RU2192812C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF UVEAL MELANOMA AND OTHER INTRAOCULAR TUMORS | 2002 |
|
RU2218069C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF IRIS MELANOMA AND PROGRESSIVE IRIS NEVUS | 2023 |
|
RU2799919C1 |
METHOD FOR PREDICTING ORBIT PSEUDOTUMOR CLINICAL COURSE SEVERITY DEGREE | 2006 |
|
RU2310861C1 |
Authors
Dates
2003-02-20—Published
2001-05-23—Filed